For Guidant, J&amp;J&#39;s resources sealed the deal
335586
After lengthy talks and stiff negotiations over price, the decision by Guidant executives to sell the company for $25.4 billion came down to the attractiveness of Johnson &amp; Johnson&#39;s deep resources.
179502
Shares of medical device maker Guidant  Corp.GDT.N jumped on Tuesday after a report saying the  company was in advanced talks to be acquired by health products  maker Johnson & Johnson JNJ.N for more than $24 billion.
584724
Johnson &amp; Johnson (JNJ), the drug and health care products company, is reportedly in advanced negotiations to buy Guidant (GDT), a leading maker of devices to treat heart and circulatory illnesses, for more than $24 billion.
16804
Johnson &amp; Johnson Chief Executive Officer William Weldon plans to use the $25 billion purchase of defibrillator maker Guidant Corp.
732516
This highly respected BDC turns in solid results, and is investor-friendly, to boot.
246083
Johnson &amp; Johnson (JNJ.N: Quote, Profile, Research) will buy Guidant Corp. (GDT.N: Quote, Profile, Research) for $23.9 billion in cash and stock, giving the health-care products
759956
Johnson & Johnson aims to seal a purchase of Guidant Corp. without immediately jettisoning the medical device maker's stent operations, sources familiar with the situation said on Thursday.
263676
Guidant Corp. (GDT.N: Quote, Profile, Research) said on Thursday it has resolved manufacturing and design problems that caused tiny fractures in its experimental
32462
Johnson &amp; Johnson, the US medical and consumer goods group, is in advanced discussions to buy Guidant, a maker of medical devices, in a deal that could be worth about $24bn (Â£12bn).
568349
Johnson &amp; Johnson, the world&#39;s biggest maker of medical devices, may buy defibrillator maker Guidant Corp. for $24 billion, people familiar with the situation said today.
470326
Johnson &amp; Johnson said late last night it will acquire Guidant for $23.9 billion, a move that will give the big drug maker a bigger share of the explosive market for heart devices.
165840
Johnson and Johnson is in negotiations to acquire Guidant, one of the largest American makers of devices to treat heart and circulatory illnesses.
455781
It has been a long and tortured courtship. For years, health-care giant Johnson &amp; Johnson (JNJ ) has held on-again, off-again acquisition talks with medical-device maker Guidant (GDT ). Now Wall Street sources say the companies are talking again.
336179
LONDON: Johnson &amp; Johnson has agreed to acquire Guidant Corp for US$25.4bil, adding electrical devices for treating heart disease to a line-up of thousands of health products ranging from Band-Aids to cardiac stents.
290458
Shares of medical device maker Guidant  Corp. GDT.N jumped on Tuesday after a report saying the  company was in advanced talks to be acquired by health products  maker Johnson & Johnson JNJ.N for more than $24 billion.
718989
Johnson & Johnson aims to seal a  purchase of Guidant Corp. without immediately jettisoning the  medical device maker's stent operations, sources familiar with  the situation said on Thursday.
351599
NEW YORK -- Johnson &amp; Johnson will acquire Guidant Corp., one of the world&#39;s leading makers of cardiac devices, for about $25.4 billion in cash and stock.